BerganKDV Wealth Management LLC Has $13.16 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

BerganKDV Wealth Management LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 2.2% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 25,796 shares of the healthcare conglomerate’s stock after acquiring an additional 557 shares during the period. UnitedHealth Group accounts for approximately 1.4% of BerganKDV Wealth Management LLC’s holdings, making the stock its 17th largest position. BerganKDV Wealth Management LLC’s holdings in UnitedHealth Group were worth $13,155,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. State Street Corp boosted its holdings in shares of UnitedHealth Group by 1.9% during the 4th quarter. State Street Corp now owns 45,559,868 shares of the healthcare conglomerate’s stock worth $22,877,432,000 after buying an additional 869,827 shares during the period. Capital International Investors boosted its holdings in shares of UnitedHealth Group by 4.3% during the 4th quarter. Capital International Investors now owns 19,342,468 shares of the healthcare conglomerate’s stock worth $9,713,058,000 after buying an additional 790,219 shares during the period. Geode Capital Management LLC boosted its holdings in UnitedHealth Group by 1.2% in the 4th quarter. Geode Capital Management LLC now owns 15,618,069 shares of the healthcare conglomerate’s stock valued at $7,821,210,000 after purchasing an additional 189,864 shares during the period. Alliancebernstein L.P. boosted its holdings in UnitedHealth Group by 2.4% in the 4th quarter. Alliancebernstein L.P. now owns 11,015,163 shares of the healthcare conglomerate’s stock valued at $5,531,154,000 after purchasing an additional 257,910 shares during the period. Finally, Norges Bank bought a new stake in UnitedHealth Group in the 4th quarter valued at $4,478,185,000. 87.48% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, CEO Andrew Witty sold 11,376 shares of the stock in a transaction that occurred on Monday, July 18th. The stock was sold at an average price of $527.90, for a total transaction of $6,005,390.40. Following the completion of the transaction, the chief executive officer now directly owns 76,559 shares of the company’s stock, valued at $40,415,496.10. The sale was disclosed in a filing with the SEC, which is available through this link. In other UnitedHealth Group news, CEO Andrew Witty sold 11,376 shares of the firm’s stock in a transaction on Monday, July 18th. The stock was sold at an average price of $527.90, for a total transaction of $6,005,390.40. Following the transaction, the chief executive officer now directly owns 76,559 shares in the company, valued at approximately $40,415,496.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO John F. Rex sold 13,183 shares of the firm’s stock in a transaction on Friday, July 29th. The stock was sold at an average price of $541.53, for a total value of $7,138,989.99. Following the transaction, the chief financial officer now owns 141,508 shares in the company, valued at $76,630,827.24. The disclosure for this sale can be found here. Insiders sold a total of 130,144 shares of company stock worth $69,269,555 over the last quarter. 0.40% of the stock is currently owned by corporate insiders.

UnitedHealth Group Trading Up 0.2 %

UnitedHealth Group stock traded up $1.31 during trading hours on Friday, reaching $535.06. The company had a trading volume of 2,373,351 shares, compared to its average volume of 2,833,444. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.77 and a quick ratio of 0.78. UnitedHealth Group Incorporated has a 12-month low of $383.12 and a 12-month high of $553.29. The firm has a market cap of $500.48 billion, a price-to-earnings ratio of 27.94, a P/E/G ratio of 1.65 and a beta of 0.76. The company has a 50-day moving average price of $506.46 and a 200 day moving average price of $499.44.

UnitedHealth Group (NYSE:UNHGet Rating) last released its earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 EPS for the quarter, topping the consensus estimate of $5.24 by $0.33. The business had revenue of $80.33 billion for the quarter, compared to the consensus estimate of $79.68 billion. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The company’s revenue for the quarter was up 12.6% compared to the same quarter last year. During the same period in the previous year, the company posted $4.70 earnings per share. Equities analysts forecast that UnitedHealth Group Incorporated will post 21.86 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 28th. Investors of record on Monday, June 20th were given a dividend of $1.65 per share. This represents a $6.60 dividend on an annualized basis and a yield of 1.23%. The ex-dividend date was Thursday, June 16th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.45. UnitedHealth Group’s dividend payout ratio is 34.46%.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of recent research reports. Raymond James increased their price objective on shares of UnitedHealth Group from $540.00 to $620.00 and gave the company a “strong-buy” rating in a research note on Tuesday, April 19th. Morgan Stanley raised their price objective on shares of UnitedHealth Group from $570.00 to $587.00 in a research report on Monday, July 18th. UBS Group raised their price objective on shares of UnitedHealth Group from $545.00 to $570.00 and gave the company a “neutral” rating in a research report on Thursday, July 21st. SVB Leerink raised their target price on shares of UnitedHealth Group from $600.00 to $625.00 and gave the company an “outperform” rating in a research note on Monday, July 18th. Finally, Cowen lifted their price objective on shares of UnitedHealth Group from $512.00 to $596.00 in a research note on Monday, April 18th. Three equities research analysts have rated the stock with a hold rating, sixteen have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus target price of $582.50.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Articles

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.